C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2002
12/19/2002	US20020194632 Transgenic knockouts of BACE-1
12/19/2002	US20020194628 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof
12/19/2002	US20020193572 Generation of glycosylated antibody; obtain cell, incubate with vector expressing preferential antibody, transfected with a vector, propagate, express vector, recover antibody
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193350 Contacting a sample containing sperm with a solution comprising a polysaccharide containing arabinose, galactose and/or hexuronic acid (PCAGH) to form a mixture, wherein the PCAGH is not arabinogalactan; separating sperm from the sample
12/19/2002	US20020193337 Gene therapy by secretory gland expression
12/19/2002	US20020193327 For therapy of eye disorders including retinitis pigmentosa, Stargardt's disease, diabetic retinopathies, retinal vascularization, or retinoblastoma
12/19/2002	US20020193316 Caloporoside derivatives, methods of their preparation and use
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193308 Recombinant protein and its use in therapy and diagnostics
12/19/2002	US20020193302 Use of FVIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/19/2002	US20020193300 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020193299 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/19/2002	US20020193287 Mixing subunit complex is cardiac troponin IC (cTnIC) solution with an active polymer to form a stabilized cTnIC-polymer conjugate
12/19/2002	US20020192826 Recombinant AAV vector-based transduction system and use of same
12/19/2002	US20020192825 Methods of use of viral vectors to deliver antigen to dendritic cells
12/19/2002	US20020192824 Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A
12/19/2002	US20020192823 Expression vector for use as tool in gene therapy
12/19/2002	US20020192822 Herpes simplex virus ICP4 is an inhibitor of apoptosis
12/19/2002	US20020192820 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/19/2002	US20020192818 Recovering cryopreserved conifer embryogenic cultures
12/19/2002	US20020192817 Generation of tyrosine hydroxylase; obtain nervous system stem cell, incubate with fibroblast growth factor, kinase and dopamine, recover differentiated cells
12/19/2002	US20020192816 Human pancreatic progenitor cells for use in cell therapy
12/19/2002	US20020192815 Active retinoic acid-free culture medium for avian totipotent embryonic cells
12/19/2002	US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192789 Novel enterokinase cleavage sequences
12/19/2002	US20020192785 For use in therapeutics, diagnostics, and as research tools
12/19/2002	US20020192782 Enzymatic polypeptide for use in the generation of pharmeceuticals
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192757 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
12/19/2002	US20020192755 Generation of preferential protein in genetically engineered cell; obtain genetically engineeredd cell, express vector, recover protein
12/19/2002	US20020192752 Compositions and methods for the treatment of immune related diseases
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192744 Useful in the nutrition of patients suffering from phenylketonuria
12/19/2002	US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders
12/19/2002	US20020192728 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/19/2002	US20020192724 Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes
12/19/2002	US20020192717 Detecting preferential particle in sample; obtain cells, incubate with sample, detect signal in cell
12/19/2002	US20020192710 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
12/19/2002	US20020192709 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor
12/19/2002	US20020192706 Nucleotide sequences coding polypeptides for use treatment of cell proliferation disorders
12/19/2002	US20020192705 Clonal expansion of T cells of unknown specificity and identification of ligand recognized by the clonally expanded T cells
12/19/2002	US20020192699 Genes and gene expression products that are differentially regulated in prostate cancer
12/19/2002	US20020192695 Detection of modulator of tumor suppressor activity; obtain sample of polypeptide, incubate with modulator, monitor adjustment in polypeptide activity
12/19/2002	US20020192686 Recovery of cells expressing preferential phenotypes; obtain cells, store phenotypic data, monitor phenotypic adjustments in cells, recover and classify phenotypes of interest
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192668 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192665 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
12/19/2002	US20020192660 Reducing effect of regulatory sequences on transcription; obtain nucleotide sequences, detect regulatory sequences, mutate, transfect into cell, culture, monitor adjustment in transcription control
12/19/2002	US20020192659 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192640 Purified active HCV NS2/3 protease
12/19/2002	US20020192639 HCV antigen/antibody combination assay
12/19/2002	US20020192638 Evaluation of cells sensitvity to anticancer agents; obtain tissue, separate, culture tissue, inoculate cells, incubate with anticancer agent, monitor sensitivity to anticancer agents
12/19/2002	US20020192637 Biological Sensor
12/19/2002	US20020192635 Kits for use in monitoring and evaluating cell metabolism
12/19/2002	US20020192261 Hyaluronic acid derivative based cell culture and biodegradable three-dimensional matrix
12/19/2002	US20020192234 Antigen strain in vehicle; inducting immunology response
12/19/2002	US20020192232 Methods and compositions for impairing multiplication of HIV-1
12/19/2002	US20020192229 MHC class I associated peptides for prevention and treatment of tuberculosis
12/19/2002	US20020192226 Production of a parvovirus vaccine in plants as viral coat protein fusions
12/19/2002	US20020192220 Compositions and methods relating to colon specific genes and proteins
12/19/2002	US20020192216 Therapeutic use
12/19/2002	US20020192209 Methods and compositions for inhibiting neoplastic cell growth
12/19/2002	US20020192200 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells
12/19/2002	US20020192198 Method for growing human organs and suborgans
12/19/2002	US20020192197 Wound repair dressings and methods for their preservation
12/19/2002	US20020192196 Method and composition for skin grafts
12/19/2002	US20020192195 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
12/19/2002	US20020192194 Production and use of dopaminergic cells to treat dopaminergic deficiencies
12/19/2002	US20020192193 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192192 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192191 Wound repair dressings and methods for their preservation
12/19/2002	US20020192190 Induction of immunological tolerance
12/19/2002	US20020192189 AAV transduction of myoblasts
12/19/2002	US20020192187 Gene transfer with adenoviruses having modified fiber proteins
12/19/2002	US20020192186 Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase
12/19/2002	DE10129010A1 Producing a transgenic plant or plant cell expressing a transgene under control of native transcription and translation elements already present in the genome is useful to give stable expression of transgenes
12/19/2002	DE10128809A1 Cell culture chamber, for a closed culture system, has glass panes flanking the chamber for illumination and observation, with channels at the membrane plate for the feeds of nutrient and gassing and sensor connections
12/19/2002	CA2465884A1 Transgenic plants synthesising high amylose starch
12/19/2002	CA2450720A1 In vivo bioreactors
12/19/2002	CA2450665A1 Processes and vectors for producing transgenic plants
12/19/2002	CA2450389A1 Cyp450-specific dna probes and primers, and biological applications thereof
12/19/2002	CA2450285A1 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	CA2450131A1 Respiratory syncytial virus
12/19/2002	CA2450113A1 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	CA2450036A1 Assay for predicting cell activity
12/19/2002	CA2449649A1 A g-protein coupled receptor and uses therefor
12/19/2002	CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	CA2449591A1 Brain expressed gene and protein associated with bipolar disorder
12/19/2002	CA2449586A1 Substrates_for the inhibition of cell or tissue growth
12/19/2002	CA2449440A1 Structural and cytoskeleton-associated proteins
12/19/2002	CA2449272A1 Intracellular signaling molecules
12/19/2002	CA2449259A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	CA2447791A1 Methods of culturing animal cells and polypeptide production in animal cells
12/19/2002	CA2447763A1 Methods for improving cell line activity in immunoisolation devices
12/19/2002	CA2447658A1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/18/2002	EP1266965A2 Recombinant antibodies for human therapy

1 ... 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 ... 1827